Resistance of human fungal pathogens to antifungal drugs.
about
Genomic Plasticity of the Human Fungal Pathogen Candida albicansDrug Resistance Is Not Directly Affected by Mating Type Locus Zygosity in Candida albicansGenetic and genomic architecture of the evolution of resistance to antifungal drug combinationsCytochrome P450 monooxygenase CYP53 family in fungi: comparative structural and evolutionary analysis and its role as a common alternative anti-fungal drug targetHigh-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal ErgolinesIdentification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatusAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisGenetic Basis of Antifungal Drug ResistanceBiofilms in chronic rhinosinusitis: systematic review and suggestions for future research.Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum.Candida albicans Sun41p, a putative glycosidase, is involved in morphogenesis, cell wall biogenesis, and biofilm formation.A phenotypic profile of the Candida albicans regulatory network.Chemogenomic and transcriptome analysis identifies mode of action of the chemosensitizing agent CTBT (7-chlorotetrazolo[5,1-c]benzo[1,2,4]triazine)Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin.Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity.Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering.Wild-type Drosophila melanogaster as a model host to analyze nitrogen source dependent virulence of Candida albicans.Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.Drug strategies targeting CYP51 in neglected tropical diseasesSystems-level antimicrobial drug and drug synergy discovery.Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates.New subfamilies of major intrinsic proteins in fungi suggest novel transport properties in fungal channels: implications for the host-fungal interactionsExploring the molecular basis of antifungal synergies using genome-wide approaches.Thionin-like peptide from Capsicum annuum fruits: mechanism of action and synergism with fluconazole against Candida species.Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.Evolution of antifungal-drug resistance: mechanisms and pathogen fitness.A novel glyco-conjugate vaccine against fungal pathogens.A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5.Molecular Characterization of Gβ-Like Protein CpcB Involved in Antifungal Drug Susceptibility and Virulence in A. fumigatusReversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia spGain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.Capisterones A and B, which enhance fluconazole activity in Saccharomyces cerevisiae, from the marine green alga Penicillus capitatus.The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.Molecular Insights into the Fungus-Specific Serine/Threonine Protein Phosphatase Z1 in Candida albicansHeteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.Photodynamic antifungal chemotherapy.Recent insights into Candida albicans biofilm resistance mechanismsImpact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.Role of bacterial biofilm in development of middle ear effusion.The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.
P2860
Q21999033-9D0FC08E-DB9B-4461-9EB0-2F81F3ED02F8Q22337052-48EBF3CA-0543-4F35-BC0B-F364F01CD0A0Q28486002-7CD83E83-9F5C-4E32-9E53-0D79C63E3364Q28542973-8D3A15C9-1116-43C5-A340-EBBDC56CB5C6Q28554843-3D1E568C-58C6-4712-B745-F7779FDD7930Q28752041-51886FCB-316F-4D35-98DE-711AC17B8E80Q28818603-7B0924E1-7B82-4921-926B-E5EF31E55753Q30434904-B8C5BB77-B490-4327-9658-298003410E29Q30999643-94B2E1D4-50FB-40CD-8F7C-F9644919B367Q33261315-B9B8808D-85ED-4558-903B-9398D67466D2Q33300915-5CE0FD02-652C-45B6-8D5A-3A05D00489C9Q33521302-6449831D-D669-4CAA-B1F6-D1618793BF23Q33536835-604E7C92-C41A-4E4D-81EF-8F4E01F67373Q33716171-E59C0657-CD0B-4A63-8EB3-A16FB9F2A4FAQ34077013-F3CC7CC0-F9B1-4F79-86AA-C1EAED5DF596Q34080293-51F3E200-9D4B-48BE-89CE-8C338BBE7D02Q34081541-002F3169-2A42-42E8-A3EF-78C961BF2531Q34352293-6A53D671-FB2A-41AB-84DE-F0F0F27A7386Q34622554-40EBAD85-6F01-430E-A6B5-A8C54F7B6FD0Q34626969-C2213BA6-965E-49FC-8DE5-B48FDC3D9CA7Q34887876-569A2C23-8CE0-40CF-9F84-D1DF4DA74799Q35223027-B07DB221-8586-42F0-A97D-8AA7C69F77E8Q35854979-E7788119-9EB1-4D86-8FEB-7D2C50DE1147Q35906637-46F39F57-60A8-4C8C-BA13-118DCE7B0F2CQ36095337-8194D177-39CA-40C0-8199-0BC948C29F44Q36161987-2A76BD6E-F2BF-415E-8E46-3DA8C88C0ED3Q36402820-5DA5B084-C301-4B77-A7ED-6C92982B6D88Q36516207-FA5C0651-B312-42C9-BB2B-B528A4219D3DQ36559089-68BAF938-1EE7-4FFA-A6A7-EA5A35D5EAA5Q36969235-DED65D1A-DA15-4E44-900D-6FEC5CB891D1Q36993519-94E71045-7224-4EC3-8FC5-85FEFFC004CEQ37074445-DD0BE30D-7D1F-4D07-9672-B7F0DAED5CF6Q37075845-6468FBCD-647F-4A71-9AC5-91E1227F480AQ37208359-E8F1E2A4-3EE1-4E16-A9C2-108D1D506464Q37247728-C03C9AFC-24A1-420B-9DB5-650B5F6F1353Q37982147-4975EF23-4E90-47F6-AF9D-FB11E98A35F6Q38131290-B48FBA46-7978-4FF9-B230-61EFF53968B9Q38467366-F082C821-2431-4787-9155-282DED6D2DEDQ39513149-270F6672-D234-4120-98E2-AF6A7632E905Q39796596-E24F3F82-48EB-404F-93DA-A948D43F32A5
P2860
Resistance of human fungal pathogens to antifungal drugs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Resistance of human fungal pathogens to antifungal drugs.
@ast
Resistance of human fungal pathogens to antifungal drugs.
@en
Resistance of human fungal pathogens to antifungal drugs.
@nl
type
label
Resistance of human fungal pathogens to antifungal drugs.
@ast
Resistance of human fungal pathogens to antifungal drugs.
@en
Resistance of human fungal pathogens to antifungal drugs.
@nl
prefLabel
Resistance of human fungal pathogens to antifungal drugs.
@ast
Resistance of human fungal pathogens to antifungal drugs.
@en
Resistance of human fungal pathogens to antifungal drugs.
@nl
P1476
Resistance of human fungal pathogens to antifungal drugs.
@en
P2093
Dominique Sanglard
P304
P356
10.1016/S1369-5274(02)00344-2
P577
2002-08-01T00:00:00Z